169 related articles for article (PubMed ID: 28043645)
1. Adaptation is mandatory for intensity modulated proton therapy of advanced lung cancer to ensure target coverage.
Hoffmann L; Alber M; Jensen MF; Holt MI; Møller DS
Radiother Oncol; 2017 Mar; 122(3):400-405. PubMed ID: 28043645
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Pencil Beam Scanned Intensity Modulated Proton Therapy in Breath-hold for Locally Advanced Non-Small Cell Lung Cancer.
Gorgisyan J; Munck Af Rosenschold P; Perrin R; Persson GF; Josipovic M; Belosi MF; Engelholm SA; Weber DC; Lomax AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1121-1128. PubMed ID: 28964587
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric feasibility of 4DCT-ventilation imaging guided proton therapy for locally advanced non-small-cell lung cancer.
Huang Q; Jabbour SK; Xiao Z; Yue N; Wang X; Cao H; Kuang Y; Zhang Y; Nie K
Radiat Oncol; 2018 Apr; 13(1):78. PubMed ID: 29695284
[TBL] [Abstract][Full Text] [Related]
4. Multiple-CT optimization of intensity-modulated proton therapy - Is it possible to eliminate adaptive planning?
Wang X; Li H; Zhu XR; Hou Q; Liao L; Jiang B; Li Y; Wang P; Lang J; Zhang X
Radiother Oncol; 2018 Jul; 128(1):167-173. PubMed ID: 29054378
[TBL] [Abstract][Full Text] [Related]
5. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
6. Organ sparing potential and inter-fraction robustness of adaptive intensity modulated proton therapy for lung cancer.
van der Laan HP; Anakotta RM; Korevaar EW; Dieters M; Ubbels JF; Wijsman R; Sijtsema NM; Both S; Langendijk JA; Muijs CT; Knopf AC
Acta Oncol; 2019 Dec; 58(12):1775-1782. PubMed ID: 31556764
[No Abstract] [Full Text] [Related]
7. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
8. Density overwrites of internal tumor volumes in intensity modulated proton therapy plans for mobile lung tumors.
Botas P; Grassberger C; Sharp G; Paganetti H
Phys Med Biol; 2018 Jan; 63(3):035023. PubMed ID: 29219119
[TBL] [Abstract][Full Text] [Related]
9. A treatment planning study of the potential of geometrical tracking for intensity modulated proton therapy of lung cancer.
Munck af Rosenschöld P; Aznar MC; Nygaard DE; Persson GF; Korreman SS; Engelholm SA; Nyström H
Acta Oncol; 2010 Oct; 49(7):1141-8. PubMed ID: 20831506
[TBL] [Abstract][Full Text] [Related]
10. Combined proton-photon therapy for non-small cell lung cancer.
Amstutz F; Fabiano S; Marc L; Weber DC; Lomax AJ; Unkelbach J; Zhang Y
Med Phys; 2022 Aug; 49(8):5374-5386. PubMed ID: 35561077
[TBL] [Abstract][Full Text] [Related]
11. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments.
den Otter LA; Kaza E; Kierkels RGJ; Meijers A; Ubbels FJF; Leach MO; Collins DJ; Langendijk JA; Knopf AC
Med Phys; 2018 Dec; 45(12):5525-5534. PubMed ID: 30229930
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.
Kesarwala AH; Ko CJ; Ning H; Xanthopoulos E; Haglund KE; O'Meara WP; Simone CB; Rengan R
Clin Lung Cancer; 2015 May; 16(3):237-44. PubMed ID: 25604729
[TBL] [Abstract][Full Text] [Related]
13. Improve dosimetric outcome in stage III non-small-cell lung cancer treatment using spot-scanning proton arc (SPArc) therapy.
Li X; Kabolizadeh P; Yan D; Qin A; Zhou J; Hong Y; Guerrero T; Grills I; Stevens C; Ding X
Radiat Oncol; 2018 Feb; 13(1):35. PubMed ID: 29486782
[TBL] [Abstract][Full Text] [Related]
14. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans.
Stuschke M; Kaiser A; Pöttgen C; Lübcke W; Farr J
Radiother Oncol; 2012 Jul; 104(1):45-51. PubMed ID: 22560714
[TBL] [Abstract][Full Text] [Related]
15. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
[TBL] [Abstract][Full Text] [Related]
16. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
17. Robust optimization in intensity-modulated proton therapy to account for anatomy changes in lung cancer patients.
Li H; Zhang X; Park P; Liu W; Chang J; Liao Z; Frank S; Li Y; Poenisch F; Mohan R; Gillin M; Zhu R
Radiother Oncol; 2015 Mar; 114(3):367-72. PubMed ID: 25708992
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
19. Spot-Scanning Proton Arc (SPArc) Therapy: The First Robust and Delivery-Efficient Spot-Scanning Proton Arc Therapy.
Ding X; Li X; Zhang JM; Kabolizadeh P; Stevens C; Yan D
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1107-1116. PubMed ID: 27869083
[TBL] [Abstract][Full Text] [Related]
20. Dose uncertainties in IMPT for oropharyngeal cancer in the presence of anatomical, range, and setup errors.
Kraan AC; van de Water S; Teguh DN; Al-Mamgani A; Madden T; Kooy HM; Heijmen BJ; Hoogeman MS
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):888-96. PubMed ID: 24351409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
